FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2136123911> ?p ?o ?g. }

• W2136123911 endingPage "1899" @default.
• W2136123911 startingPage "1892" @default.
• W2136123911 abstract "Heparin has been used for years as a locking solution in totally implantable venous access devices. Normal saline (NS) might be a safe alternative for heparin. However, evidence of non-inferiority of NS versus heparin is lacking.We randomly allocated 802 cancer patients with a newly inserted port either to heparin lock (300 U/3 ml) or to NS lock groups in a 1:1 assignment ratio. The primary outcome was the number of functional complications, which was defined as 'easy injection, impossible aspiration' at port access. Secondary outcomes included all functional problems and catheter-related bacteraemia. We hypothesised that NS locks do not cause more functional problems and catheter-related bacteraemia than heparin locks. Non-inferiority is established if the upper limit of the confidence interval (CI) for the relative risk of NS versus heparin is <1.4.Three hundred and eighty-two patients from the NS group and 383 from the heparin lock group were included in the analysis. The incidence rate of our primary outcome (easy injection, impossible aspiration) was 3.70% (95% CI 2.91%-4.69%) and 3.92% (95% CI 3.09%-4.96%) of accesses in the NS and heparin groups, respectively. The relative risk was 0.94% (95% CI 0.67%-1.32%). Catheter-related bloodstream infection was 0.03 per 1000 catheter days in the NS group and 0.10 per 1000 catheter days in the heparin group.NS is a safe and effective locking solution in implantable ports if combined with a strict protocol for device insertion and maintenance." @default.
• W2136123911 created "2016-06-24" @default.
• W2136123911 creator A5011265760 @default.
• W2136123911 creator A5014386325 @default.
• W2136123911 creator A5019240012 @default.
• W2136123911 creator A5037313267 @default.
• W2136123911 creator A5048555630 @default.
• W2136123911 creator A5053368690 @default.
• W2136123911 creator A5066776334 @default.
• W2136123911 creator A5074163096 @default.
• W2136123911 creator A5083609201 @default.
• W2136123911 creator A5086331193 @default.
• W2136123911 date "2013-07-01" @default.
• W2136123911 modified "2023-10-16" @default.
• W2136123911 title "Comparing normal saline versus diluted heparin to lock non-valved totally implantable venous access devices in cancer patients: a randomised, non-inferiority, open trial" @default.
• W2136123911 cites W1769984198 @default.
• W2136123911 cites W1891974669 @default.
• W2136123911 cites W1978614601 @default.
• W2136123911 cites W2001280008 @default.
• W2136123911 cites W2010396325 @default.
• W2136123911 cites W2012070416 @default.
• W2136123911 cites W2020426870 @default.
• W2136123911 cites W2020947063 @default.
• W2136123911 cites W2021672810 @default.
• W2136123911 cites W2038635125 @default.
• W2136123911 cites W2044766576 @default.
• W2136123911 cites W2051106992 @default.
• W2136123911 cites W2063534891 @default.
• W2136123911 cites W2068705544 @default.
• W2136123911 cites W2084219521 @default.
• W2136123911 cites W2084572292 @default.
• W2136123911 cites W2086716026 @default.
• W2136123911 cites W2092915773 @default.
• W2136123911 cites W2122145096 @default.
• W2136123911 cites W2128645516 @default.
• W2136123911 cites W2137635384 @default.
• W2136123911 cites W2145400237 @default.
• W2136123911 cites W2146979304 @default.
• W2136123911 cites W2153777805 @default.
• W2136123911 cites W2157748009 @default.
• W2136123911 cites W2161836876 @default.
• W2136123911 cites W4205175489 @default.
• W2136123911 doi "https://doi.org/10.1093/annonc/mdt114" @default.
• W2136123911 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23553060" @default.
• W2136123911 hasPublicationYear "2013" @default.
• W2136123911 type Work @default.
• W2136123911 sameAs 2136123911 @default.
• W2136123911 citedByCount "90" @default.
• W2136123911 countsByYear W21361239112014 @default.
• W2136123911 countsByYear W21361239112015 @default.
• W2136123911 countsByYear W21361239112016 @default.
• W2136123911 countsByYear W21361239112017 @default.
• W2136123911 countsByYear W21361239112018 @default.
• W2136123911 countsByYear W21361239112019 @default.
• W2136123911 countsByYear W21361239112020 @default.
• W2136123911 countsByYear W21361239112021 @default.
• W2136123911 countsByYear W21361239112022 @default.
• W2136123911 countsByYear W21361239112023 @default.
• W2136123911 crossrefType "journal-article" @default.
• W2136123911 hasAuthorship W2136123911A5011265760 @default.
• W2136123911 hasAuthorship W2136123911A5014386325 @default.
• W2136123911 hasAuthorship W2136123911A5019240012 @default.
• W2136123911 hasAuthorship W2136123911A5037313267 @default.
• W2136123911 hasAuthorship W2136123911A5048555630 @default.
• W2136123911 hasAuthorship W2136123911A5053368690 @default.
• W2136123911 hasAuthorship W2136123911A5066776334 @default.
• W2136123911 hasAuthorship W2136123911A5074163096 @default.
• W2136123911 hasAuthorship W2136123911A5083609201 @default.
• W2136123911 hasAuthorship W2136123911A5086331193 @default.
• W2136123911 hasBestOaLocation W21361239111 @default.
• W2136123911 hasConcept C119599485 @default.
• W2136123911 hasConcept C126322002 @default.
• W2136123911 hasConcept C127413603 @default.
• W2136123911 hasConcept C141071460 @default.
• W2136123911 hasConcept C168563851 @default.
• W2136123911 hasConcept C174839445 @default.
• W2136123911 hasConcept C2777397205 @default.
• W2136123911 hasConcept C2777557582 @default.
• W2136123911 hasConcept C2780446839 @default.
• W2136123911 hasConcept C2781267111 @default.
• W2136123911 hasConcept C32802771 @default.
• W2136123911 hasConcept C42219234 @default.
• W2136123911 hasConcept C44249647 @default.
• W2136123911 hasConcept C71924100 @default.
• W2136123911 hasConcept C78519656 @default.
• W2136123911 hasConcept C82789193 @default.
• W2136123911 hasConceptScore W2136123911C119599485 @default.
• W2136123911 hasConceptScore W2136123911C126322002 @default.
• W2136123911 hasConceptScore W2136123911C127413603 @default.
• W2136123911 hasConceptScore W2136123911C141071460 @default.
• W2136123911 hasConceptScore W2136123911C168563851 @default.
• W2136123911 hasConceptScore W2136123911C174839445 @default.
• W2136123911 hasConceptScore W2136123911C2777397205 @default.
• W2136123911 hasConceptScore W2136123911C2777557582 @default.
• W2136123911 hasConceptScore W2136123911C2780446839 @default.
• W2136123911 hasConceptScore W2136123911C2781267111 @default.
• W2136123911 hasConceptScore W2136123911C32802771 @default.
• W2136123911 hasConceptScore W2136123911C42219234 @default.

• next